JPM Thematics - Genetic Therapies C (dist) - GBP/  LU2314628723  /

To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally. Will invest in equities of companies that have been identified by the Investment Manager as being involved in research, development, production or marketing of genetic therapies and their associated businesses anywhere in the world, including emerging markets. The Investment Manager supervises and monitors the theme identification and portfolio construction process and actively selects securities for the Sub-Fund"s portfolio. At least 90% of companies purchased will be analysed against the theme.

To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.